Dealing with diabetes could soon be a lot easier as researchers have developed an injection that can restore blood sugar levels to normal for more than two days without any side effects.
In mice with diet-induced diabetes - the equivalent of type-2 diabetes in humans - a single injection of the protein FGF1 was found enough to control blood sugar levels.
"FGF1 offers a new method to control glucose in a powerful and unexpected way," said Ronald Evans from Salk Institute for Biological Studies in the US.
The discovery could lead to a new generation of safer, more effective diabetes drugs.
Sustained treatment with the protein does not merely keep blood sugar under control, but also reverses insulin insensitivity, the underlying physiological cause of diabetes, the findings showed.
Equally exciting, the newly developed treatment did not result in side effects common to most current diabetes treatments.
For the study, researchers injected doses of FGF1 into obese mice with diabetes to assess the protein's potential impact on metabolism.
They found that with a single dose, blood sugar levels quickly dropped to normal levels in all the diabetic mice.
"Many previous studies that injected FGF1 showed no effect on healthy mice," said Michael Downes, a senior staff scientist at Salk Institute.
"However, when we injected it into a diabetic mouse, we saw a dramatic improvement in glucose levels," Downes added.
The study appeared in the journal Nature.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
